Skip to main content
SpringerLink
Log in

Cardiovascular drugs unaffordable in many communities

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Khatib R et al. Availability and affordability of cardiovascular disease medicines and their effect on use in high-income, middle-income, and low-income countries: an analysis of the PURE study data. Lancet : 21 Oct 2015. Available from: URL: http://dx.doi.org/10.1016/S0140-6736(15)00469-9

    PubMed  Google Scholar 

  2. Niessen LW, et al. Universal access to medicines. Lancet : 21 Oct 2015. Available from: URL: http://dx.doi.org/10.1016/S0140-6736(15)00552-8

    PubMed  Google Scholar 

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Cardiovascular drugs unaffordable in many communities. PharmacoEcon Outcomes News 740, 15 (2015). https://doi.org/10.1007/s40274-015-2570-3

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40274-015-2570-3

Search

Navigation